Puma Biotechnology's market cap is currently $143.34M. The company's EPS TTM is $0.474; its P/E ratio is 6.12; Puma Biotechnology is scheduled to report earnings on February 27, 2025, and the estimated EPS forecast is $0.09. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 235.64M	$ 228.00M	$ 253.20M	$ 225.10M	$ 272.30M
Gross Profit	$ 172.96M	$ 172.90M	$ 189.50M	$ 185.70M	$ 235.50M
Operating Income	$ 32.64M	$ 23.70M	$ -8.90M	$ -30.40M	$ -39.10M
EBITDA	$ 47.52M	$ 20.97M	$ -5.40M	$ -38.54M	$ -55.72M
Net Income	$ 21.59M	$ 912.00K	$ -29.10M	$ -60.00M	$ -82.72M
Balance Sheet
Cash & Short-Term Investments	$ 95.94M	$ 76.20M	$ 63.10M	$ 85.30M	$ 60.00M
Total Assets	$ 230.53M	$ 222.06M	$ 226.59M	$ 244.22M	$ 234.91M
Total Debt	$ 111.49M	$ 114.28M	$ 116.64M	$ 120.95M	$ 120.23M
Net Debt	$ 26.91M	$ 38.08M	$ 53.54M	$ 35.65M	$ 60.23M
Total Liabilities	$ 177.09M	$ 200.45M	$ 229.03M	$ 250.17M	$ 217.44M
Stockholders' Equity	$ 53.44M	$ 21.60M	$ -2.40M	$ -6.00M	$ 17.50M
Cash Flow
Free Cash Flow	$ 14.37M	$ -22.80M	$ 20.70M	$ -19.25M	$ 22.09M
Operating Cash Flow	$ 27.01M	$ -15.80M	$ 20.70M	$ 800.00K	$ 22.40M
Investing Cash Flow	$ -19.13M	$ 7.10M	$ -10.90M	$ 23.30M	$ 5.20M
Financing Cash Flow	$ 0.00	$ 12.20M	$ -31.90M	$ 100.00K	$ -67.10M

Currency in USD

Puma Biotechnology Earnings and Revenue History

Income Statement >

Puma Biotechnology Debt to Assets

Balance Sheet >

Puma Biotechnology Cash Flow

Cash Flow >

Puma Biotechnology Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing